* Pulmonx Corp LUNG.OQ LUNG.O is expected to show a rise
in
quarterly revenue when it reports results
* The Redwood City California-based company is expected to
report
a 21.4% increase in revenue to $16.386 million from $13.5
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. The company's guidance on
October 10 2023, for the period ended September 30, was for
revenue of $17.600 million.
* Refinitiv's mean analyst estimate for Pulmonx Corp is for
a
loss of 43 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pulmonx
Corp is
$16.5, above its last closing price of $8.22.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.44 -0.44 -0.43 Beat 1.6
Mar. 31 2023 -0.44 -0.44 -0.42 Beat 4.5
Dec. 31 2022 -0.43 -0.42 -0.38 Beat 8.7
Sep. 30 2022 -0.40 -0.40 -0.38 Beat 4.2
Jun. -0.42 -0.41 -0.40 Beat 2.4
30 2022
Mar. 31 2022 -0.38 -0.37 -0.43 Missed -15.9
Dec. 31 2021 -0.36 -0.36 -0.35 Beat 2.9
Sep. 30 2021 -0.37 -0.37 -0.28 Beat 24.8
This summary was machine generated October 28 at 01:31 GMT. All
figures in US dollars unless otherwise stated